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Many neuropeptides are present in the peripheral nerves of 
human skin and are distributed from the intraepidermis to 
subcutaneous appendages, and those peptides are considered 
to be involved in the pathogenesis of various inflammatory 
dermatoses. In this investigation, we determined the effects 
of various neuropeptides on intracellular cyclic adenosine-
5'-monophosphate (AMP) formation in cultured human 
keratinocytes. Among the many peptides tested, calcitonin 
gene-related peptide (CGRP), vasoactive intestinal polypep-
tide (VIP), peptide histidine-methionine (PHM), and 
growth hormone releasing factor (GRF) stimulated a rapid 
and marked formation of intracellular cyclic AMP in kerati-
nocytes in a dose-dependent manner. The direct association 
of the receptors for CGRP and VIP with adenylyl cyclase in 
keratinocytes was confirmed by the findings that CGRP and 
Several neuropeptides have been shown to exist in mam-malian skin, in varying amounts, by immuno-histochem-istry or radio immunoassay (RIA) [1,2]. The cutaneous neuropeptides found in human skin consist of more than 20 kinds of peptides including: calcitonin gene-related 
peptide (CGRP), neuropeptide Y (NPY), peptide histidine-methi-
onine (PHM), substance P (SP), and vasoactive intestinal peptide 
(VIP) [1]. Some peptides are present not only in the cutaneous 
nerves but also in Merkel cells, mast cells, dendritic cells, Langer-
hans celis, or even in the epidermal keratinocytes of human skin [1] . 
The neuropeptides released from nerve endings by axonal reflex are 
considered to be the important mediators in local inflammation, and 
their effects on the cutaneous inflammatory and vascular cells have 
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VIP stimulated the enzyme activity in membrane prepara-
tions derived from cultured keratinocytes in the presence of 
guanosine triphosphate (GTP). On the other hand, neuro-
peptide Y (NPY) showed an inhibitory effect on forskolin-
induced cyclic AMP accumulation in keratinocytes. This in-
hibitory effect of NPY was completely eliminated by 
glucocorticoid pretreatment of cultured keratinocytes. Fur-
thermore, the presence of peptides that substantially increase 
intracellular cyclic AMP accumulation also stimulated DNA 
synthesis and proliferation in a human keratinocyte cell line 
in a dose-dependent manner. These results suggest that neur-
opeptides work directly as biologic modulators of keratino-
cytes through the cyclic AMP cascade. Key words: neuro-
peptides/G protein - coupled receptors/intracellular second 
messengers.] Invest DermatoI101:646-651, 1993 
been well investigated. These peptides are thought to be involved in 
the pathogenesis of certain inflammatory dermatoses, such as psori-
asis, psychologic urticaria, and the erythematous reaction referred 
to as neurogenic inflammation [3 - 5]. However, the effects of neur-
opeptides on human epidermis, including keratinocytes, melano-
cytes, and dermal fibroblasts, have remained enigmatic, and even 
the presence of receptors for neuropeptides has not been deter-
mined. 
Almost all cutaneous neuropeptides transduce signals to target 
celis through specific membrane receptors, which belong to the 
large family of G protein-coupled receptors [6] . This receptor fam-
ily possesses a common structural characteristic of the seven trans-
membrane domain arrangement [7]. The G protein - coupled recep-
tors activate effector systems of the target cells such as adenylyl 
cyclase, phospholipase C, or ion channels, and in turn modulate the 
concentrations of one or more small intracellular signaling mole-
cules, referred to as intracellular second messengers. The most im-
portant second message systems are the cyclic AMP cascade and 
phosphatidylinositol (PI) hydrolysis/Ca++ influx. Cyclic AMP and 
PI/Ca++ signals are generated through different pathways, both 
involving G proteins, and act in turn to alter the activities of protein 
kinase A and protein kinase C, respectively [8,9] . 
Until now, adenosine, catecholamine, histamine, and prostaglan-
din E have been demonstrated to be the agents that increase intracel-
lular cyclic AMP formation in keratinocytes and result in the activa-
tion of protein kinase A [10 -13]. However, the true physiologic 
roles of the cyclic AMP cascade and the subsequent protein phos-
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h oryla tion in keratinocytes still remain unknown. There have 
been m.any contradicto ry reports concerning the stimulatory or in-
hibitory effects on the proliferation ofkeratinocytes induced by the 
levation of intracel lular cyclic AMP level [14-20]. To provide a ~etter understanding of the roles of neuropeptides in human skin, in 
the present study w e investi ga tedwhi~h peptides d irectly stimulate 
r inhibit the adenylyl cyclase activity 111 keratlllocytes, and w e give 
~vidence showing th e distinct stimulatory effects of neuropeptides 
on cell proliferatio n , which stimul ate the intracellular cyclic AMP 
fo rma tion. 
MATERIALS AND METHODS 
Materials Materials were obtained from the followin g sources: Oul-
b cco 's modified Eagle's medium (OMEM) from Nissui Pharmaceutical Co. 
('~okYO ' Japan); fetal bovine serum (FBS) from Gibco Laboratories (New 
York, NY); serum-free keratinocyte growth medium (KGM) fromC lone-
. s C o rp . (San Diego, CAl; cyclic AMP RIA kit from Amersham (Tokyo, 
J~pan); 3_isobutyl-l-methylxanthine (IBMX) and forskolin from Nacalai 
Tesque (Kyoto, Japan) . All other chemicals were of rcagent grade. 
Peptide Preparation Peptides tested in this experiment were as follows: 
angiote n sin II , atnal natnuretlc peptide , bombes ll1, bradyklllln ,cholecysto-
kinin, ca icitollln gene-related peptide , endothehn-l , metlllonll1~enkepha­
r n gal a n in, growth hormone releaslllg factor, a-melanocyte stllllulatlllg 
~o;mone, neurom~din K, neuropeptide Y, neurotensin, peptide histidine-
methionine, secret111, somatos.tat111, substance K, substance P, vasoactive 111-
stinal peptide, and vasopress111. All peptldes were purchased from Peptldes 
~:Stitute (Osaka, Japan). Pep tides were resolved at the concentration of 0.1 
roM and stored in small aliquots at - BO "C. 
Cell Cultures Primary cultured nor?1a1 human epidermal keratinocytes 
(NHEKs) isolated from neonatal fores k111s were purchased from Kurabo Co. 
(Tokyo, J apan) . NHEK cells were grown in KGM, which consists of modi-
fied MCDB153 medium supplemented with 0.4% (v/ v) bovine pituitary 
xtract (BPE), 0.5 Jlg/ml hydrocortisone, 5.0 mg/ml insulin , and 10 ng/ml 
~GF . The standard calcium concentration .of KGM was 0.15 111M. Cells 
ere used in second or third passage for thiS assay. Human squamous cell 
;:rcinorna line, HSC-l , originally established from undiffcrentiated squa-
mOUS cell carcinoma of skin , was maintaincd in monolayer culture in 
o MEM containing 10% FBS [21]. Cells were cultured in a humidified 
atmosphe re containing 5% CO 2 at 37·C. 
Measurements of Intracellular Cyclic AMP Accumulation Cyclic 
AMP levels in cells were determined in the presence of 1 mM IBMX as 
reported previously [22,23]. Briefl y, cultured cells were seeded at a density of 
1-2 X 105 cells/well and grown for 2 d to confluency in 12- or 24-wel l 
plates. The cells were washed twice with PBS and incubated for 15 min and 
then incubated with PBS containing 1 mM IBMX for 15 min at 37"C. The 
reaction was started by replacing the PBS with fresh PBS containing 1 mM 
rnMX and test agents. After incubat.ions were completed, the medium was 
aspirated, and the reaction was stopped with 5% (w/v) trichloroacetic acid 
(TCA). Cyclic AMP formed v.:as measured on the T CA extract after ether 
extraction by cychc AMP radiOimmunoassay (RlA) bt. For the assay of 
ligands that inhibit adenylyl cyclase, forskolin was added to the il~cubation 
medium at the concentratIOn of 1 0 pM. In the sc reclUng assay, peptldes were 
added at the concentration of 0.1 pM. 
Measurement of Adenylyl Cyclase Activities Adenylyl cyclase activi-
ties were determined as described previously [22,23] . NHEK and HSC-l 
cells were cultured as described above, and suspended in 62.5 mM Tris-CI 
(pH 7.4) , 2 mM EOTA, and 2 mM dithiothreitol (OTT). After sonication 
and centrifugation at 540,000 X g for 10 min, the pellet of sonicated ce lls 
was resuspended in 10 mM T ris-CI (pH 7.4) and 1mM OTT and used as the 
membrane fraction. The standard reaction assay mixture contained 1 mM 
fOTA, 5 mM MgCI 2 , 0.5 mM IBMX, 0.5 mM ATP, 1mM OTT, and 40 JI g 
of the m embrane fraction in 100 ml of 50 111M Hepes (pH 7.4) . Reactions 
were started by the addition of the membrane fraction, and carried out for 
indicated times at 37 · C, and terminated by the addition of 10% T CA (100 
pi). The cyclic AMP formed was thcn measured on the T CA extract after 
ether extraction by cyclic AMP RIA kit. 
Cell Proliferation Assay HSC-1 cells were subcultured in quadruplicate 
at approximately 3 X 10' cells per well in OMEM supplemented with 1 % 
FBS. After 24 h incubation, medium was changed to fresh medium contain-
ing 1 % FBS with or without 10- 8 M of the tested peptide. The cell number 
in each well was counted by Coulter counter daily after peptide application. 
Medium was changed daily to fresh medium containing each tested peptide. 
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Figure 1. Effects of various cutaneous neuropeptides on intracellular cyclic 
AMP accumulation 111 keratlnocytes. NHEK cells were cultured in 0.1 5 mM 
(light obliqlle colli III "s) or 1.2 mM calcium (dark obliq lle colli mIlS) in KGM, and 
HSC-l cells (hatched COlllmllS) were incubated with 10- 7 M of each neuro-
peptide for 10 min and the amount of cyclic AMP formation was deter-
mined. A) Stimulatory effects of l1europeptides on cyclic AMP formation. 
The values are &iven as times increases of t.he amount of cyclic AMP formed 
III control cel ls lllcubated without peptides. B) Inhibitory effects on fo rsko-
1ll1-111duced cycliC AMP formation. The amount of cycl ic AMP was deter-
lluned 111 the presence of forskolin, and the values were given as percentage 
of control treated w ith forskolin only. Other tested pCp tides not present in 
Fig 1 showed no Significant effects in cyclic AMP formation in both NHEK 
a,~d HSC-l cells: The values are means ± SO of triplicate experiments of 
tnphcate determ111ations. 
DNA Synthesis Assay HSC-l ce lls were cultured in 24-well plates to 
approxllnately 50% confluency in OMEM supplemented with 0. 5% FBS for 
24 h pnor to peptide application. Peptides were added to cul tured medium at 
the concentration of 3 X 10- 7 M. After 12 h incubation cells were labeled 
for 3 h with 1.0 p Ci/tnl [3H] thymidine in fresh medium ~upplemented with 
each peptide. Cells were washed with PBS three times and lysed with 2 N 
NaOH for 15 nun and neutralized with 2 N HC!. Lysate was precipitated by 
the addmon of four volumes of 10% icc-cold T CA and collected on a glass 
fi lter, and then measured with a liquid scinti llation coumer. 
RESULTS 
Stimulatory Effects of Neuropeptides on Cyclic AMP 
Formation .T o determ.ine. the presence of the neuropeptide re-
ceptors that stllllu late or l11hlblt adenyly l cyclase activity in kerati-
nocytes, w e m easured intracellular cyclic AMP formation after th e 
applicatio n o f various peptides to cultured keratinocytes. W e used 
two types of cultured keratinocytes, NHEK and HSC -1 cells to 
avoid variance in the results due to the cultured cells' characteris'tics 
and cult~lre conditions. T o ensure that changes in cycl ic AMP levels 
are not 1I1f1uenced by alteration in cyclic AMP phosphodies terase, 
w e added the phosphodiesterase inhibitor , lBMX, to the assay me-
dIUm. lBMX alone produced no appreciable effects o n intracellular 
c.rclic AMP accumulatio n induced by peptide or forsko lin applica-
tio n. (data not shown) . W e tested 21 kinds o f peptides, including 
anglOtenSl11 . II, atnal natnuretlc peptide, bombesin, bradykinin , 
ch~lecystok1l1111 , C GRP, endo thelin-1, m ethio nin-enkephalin , ga-
lan1l1, growth ho rmone releas1l1g fac tor (G RF), a -melanocyte stim-
u.lat1l1g hormone, neuromedin K, NPY, neuro tensin, PHM, secre-
t1l1 ,. somatostatll1 , substance K, SP , VIP, and vasopressin , all of 
which have been. deterl11l1led to be present in human skin by im-
muno-hlstochemlstry [1]. First we examined the stimulatory effects 
of neuropeptldes on cyclic AMP formation in cultured keratino-
cytes. Amo ng the peptides tested in this experiment, CGRP, VIP, 
and PHM w ere fo und to evoke a rapid and substantial increase in the 
intracellular cyclic AMP accul11ulation in both NHEK and HSC -1 
cells (Fig lA) . The maximal stimulatio n of cyclic AMP formation 
w as sixfold higher than basa l level w ith the applicatio n of CGRP , 
and 30 - 40 times higher with PHM and VIP w hen tes ted in H SC-1 
c~lI s; whereas the correspo nding m aximums w ere approximately 
eightfold h igher With C G RP, and 8- 10 times higher w ith PHM 
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Figure 2. Time courses of peptides inducing the accumulation of cyclic 
AMP. NHEK cells cultured in standard KGM were incubated with 10- 7 M 
of CGRP (opell circles) and VIP (opell squares) for the indicated time in the 
presence of IBMX, and cyclic AMP accumulation was determined. The 
va lues are given as times increase of the control level and are the means of 
duplicate determinations. 
and VIP in NHEK cells. GRF and secretin showed a lower but 
consistent increase of cyclic AMP level (a four- to sevenfold and a 
twofold increase, respectively) in NHEK and HSC-l cells (Fig 1A). 
Peptides other than CGRP, PHM, VIP, GRF, and secretin showed 
no significant increase in either NHEK or HSC-1 cells. To deter-
mine the relationship between the culture condition of keratino-
cytes and cyclic AMP accumulation, we compared the cyclic AMP 
levels in NHEK cells cultured in two different concentrations of 
calcium; one was cultured in KGM with the standard calcium con-
centration of 0.15 mM (low Ca), and the other was preincubated in 
KGM with calcium concentration of 1.2 mM (high Ca) 24 h prior 
to peptide application. The increase of cyclic AMP formation from 
basal level was slightly higher in the differentiated NHEK cells 
precultured in high-Ca medium than those cultured in standard 
low-Ca medium (Fig 1A in columns of NHEK low and high Ca). 
As shown in Fig 2, the increase of cyclic AMP accumulation was 
clearly detectable at 1 min and reached maximal levels 10 min after 
the application of CGRP and VIP. To characterize the potency and 
the relative efficiency of each neuropeptide on keratinocytes, we 
determined dose-response curves of cycl ic AMP formation. In Fig 3, 
increases of cycl ic AMP accumulation after CGRP, VIP, and PHM 
application of indicated concentrations measured in NHEK cells 
and those of VIP, PHM, GRF, and secretin measured in HSC-1 
cells, respectively, are shown. In this experiment, cyclic AMP levels 
were measured by incubating with each peptide for 10 min. A simi-
lar dose-dependent profile of cyclic AMP formation was observed 
utilizing NHEK and HSC-1 cells for CGRP, VIP, PHM, and GRF 
applications, although the maximal stimulation level varied be-
NHEK HSC-1 
____ secretin 
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Figure 3. Dose response curves of neuropeptides on cycl ic AMP formation. 
NHEK and HSC-l ce lls were incubated with indicated concentrations of 
CGRP (opell circles), VIP (opell squares), PHM (closed circles) , GRF (opell 
triallgies), and secretin (closed squares) for 10 min and evaluated for cyclic 
AMP accumulation. The values indicated are means ± SO of triplicate ex-
periments of duplicate determinations. 
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Figure 4. Inhibitory effect of NPY on forskolin-stimulated cycl ic AMp 
formation . HSC-l cel ls were precultured in DMEM with 10% FRS (opell 
squares), III standard KGM III the presence.of glucocorticoid (closed circles) , 
and III KGM WIthout glucocortIcOId (opw mcles). Cells were incubated with 
IIldlcated concentratIOn ofNPY III the presence.of forsko lin (10 liM) and the 
amounts of cyclic AMP formatIon were deternuned. The values are given as 
picomol of cyclic AMP per well. The va lues are means ± SO of quadrupl"_ , 
cate experiments of triplicate determinations. I 
tween each cell type. An increase in cycl ic AMP accumulation over 
the basal levels was seen at concentrations of approximately 10- 10 M 
CGR~, ~O-IO M VIP~ 3 X 10-9 M PHM, 10-8 M GRF, and 10-7 M I 
secretlI1 111 both cellllI1es. The ECso values (the effective concentra_ 
tion for half-maximal response) of CGRP and VIP in NHEK cells 
were determined to be approximately 3 X 10-9 M and 3 X 10-10 
M, respectively. PHM, GRF, and secretin did not reach maximal I 
levels even with the appl ication of 10- 6 M or more of highly Con-
centrated peptide (Fig 3). 
Inhibitory Effect of Neuropeptide on Cyclic AMP 
~ormation . We also examined. the inhibitory effect of neuropep_ 
tides on cycliC AMP formations 111 cultured keratinocytes. Incuba_ 
tion with forskolin (10 ,uM) evoked an approximately 30 - 50 times 
increase in cyclic AMP compared with those of no forskolin treat_ 
ment in both NHEK and HSC-1 cells. Forskolin-stimulated accu-
mulation of cyclic AMP was not reduced, but accelerated by the 
additIOn of CGRP, PHM, VIP, GRF, and secretin in NHEK and 
HSC-1 cells (data not shown). In contrast, NPY revealed an inhibi-
tory effect on forskolin-induced cyclic AMP formation in HSC- l 
cells (Fig 1B). Figure 4 shows dose-response curves for the inhibi- , 
tion of forskolin stimulated cyclic AMP formation in HSC-1 cells 
by the addition of NPY. The stimulation of cylic AMP formation 
was reduced in a dose-dependent manner by NPY and suppressed up 
to 80% of forskollI1-stimulated level With the application of 10-7 M 
NPY. The ECso of NPY for the inhibition of forskolin-stimulated 
cyclic AMP accumulation was approximately 3 X 10- 9 M. The fact 
that the application of 10-6 M NPY suppresses cyclic AMP forma-
tion by only 5-10% of forskolin alone is possibly due to the 
crossreactivity of NPY at concentrations above physiologic levels 
with some other ~eceptors that might activate adenylyl cyclase. 
However, tillS lI1hlbltory effect was not observed in NHEK cell 
cultured in both low-Ca and high-Ca concentrations of KGM 
which contained 0.5 ,ug/ml hydrocortisone. III 11;110 and ;11 lIit,,; 
studies have shown that glucocorticoids alter the activities of G 
protein-coupled receptors. The substance P receptor was reported to 
be downregulated by glucocorticoids at the level of gene transcrip_ 
tion [24], whereas p-adrenergic receptor was shown to be upregu-
lated by glucocorticoids [25]. 
Because the major action of steroid hormones is to regulate the 
transcription of target genes, we attempted to determine whether 
the inhibitory effect of NPY on cyclic AMP accumulation was 
~no?ulated by gl ucocorticoids, and whether the discrepancy of the 
1I1hlbitOry effect of NPY observed in HSC-1 and NHEK cells was 
due to the presence of glucocorticoids. HSC-1 cells were preincu-
bated III three different media pnor to NPY addition: one in DMEM 
with 10% FBS; one in the standard KGM, which contained hydro-
cortisone; and the other in hydrocortisone-free KGM. Twenty-four 
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Figure 5. Time courses of the activation of adenylyl cyclase activity in 
membrane fraction derived from NHEK cells. Adenylyl cyclase activity was 
determined in the presence of the following agents for indicated times: (opw 
squares) membrane fraction from NHEK cells together with 100 nM VIP 
and 100 J1.M GTP; (open circles) membrane fraction together with 100 nM 
CGRP and 100 J1.M GTP; (closed circles) membrane fraction with 100 nM 
VIP without the addition of GTP; (closed squares) membrane fraction with 
100 ).lM GTP without the addition of peptide; (opell triangles) membrane 
fraction when both peptide and GTP were omitted. The values are means ± 
5D of triplicate experiments of duplicate determinations. 
hours later, HSC-l cells were treated ~ith NPY and the intracellu-
lar cyclic AMP levels were measured In the presence of forskoll11 
and IBMX. Whereas the inhibitory effect of NPY on forskolin-
stimulated cyclic AMP accumulation was observed in both cells 
reincubated in DMEM and in KGM without hydrocortisone, 
ksc-t cells precultured in the standard KGM showed no signifi-
cant reduction of cyclic AMP levels with the addition ofNPY (Fig 
4). HSC-l ~ells'pr~c~ltured in the two glucocorticoid-free me?ia 
showed similar Inhibitory responses In a dose-response curve With 
, the addition ofNPY. The activity of the NPY receptor is shown to 
be downregulated by glucocorticoids, and the absence of inhibitory 
effects of NPY in NHEK cells is thought to be due to the effect of 
glucocorticoids present in the cultured media. 
CGRP and VIP Stimulate Direct Activation of Adenylyl Cy-
clase in Keratinocytes Neuropeptide-induced cyclic AMP ac-
cumulation in keratinocytes may result from the direct linkage of 
the cell membrane receptor for each peptide to adenylyl cyclase 
through G protein. Alternatively, the stimulation of the cyclic AMP 
cascade may occur as a secondary effect of the other second message 
systems, such as PI hydrolysis, arachidonic acid release, or cyclic 
GMP formation. To investigate these possibilities, we measured 
adenylyl cyclase activities in membrane preparations ofNHEK and 
HSC-l cells. Figure 5 shows the results of a representative assay of 
adenylyl cyclase activities in the membrane fraction ofNHEK cells 
assayed with CGRP and VIP. The addition of 10- 7 M CGRP and 
VIP together with 100 JiM GTP markedly increased the adenyly l 
cyclase activity in membrane fractions of both NHEK and HSC-l 
cells (data of HSC-l cells not shown) . The activity of adenylyl 
cyclase in the membrane fraction of NHEK cells stimulated with 
VIP was approximately twofold higher than in those stimulated 
with CGRP. PHM and GRF similarly activated adenylyl cyclase in 
membrane fractions of both NHEK and HSC-l cells with a lower 
stimulatory effect for cyclic AMP formation than for CGRP or VIP 
(data not shown). The results presented in Fig 5 demonstrate that 
both CGRP and VIP directly stimulate adenylyl cyclase activity 
through membrane-bound G protein in keratinocytes. 
Stintulation ofKeratinocyte Proliferation and DNA Synthe-
sis by the Neuropeptides That Activate Cyclic AMP 
Formation To further study the biologic actions of intracellular 
cycl ic AMP accumulation in keratinocytes, we analyzed the effects 
of neuropeptides on the mitogenicity and DNA synthesis activity of 
HSC-t cells. After cultivation of cells under serum-starved condi-
tions, neuropeptides were added, and the cell number and the 
amount of thymidine incorporation was determined per well. The 
results showed a good correlation with the results of experiments on 
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intracellular cyclic AMP formation . Among th e peptides men-
tioned above, treatment with CGRP, GRF, PHM, and VIP showed 
significant increases of thymidine uptake into HSC-1 cells (Fig 6A). 
Obvious stimulat.ory effectsof these neuroreptides were also shown 
111 cell proliferation analySIS. Increases 0 approximately 1.3 -1.5 
times were shown per 24-h period compared to the growth rate of 
control cells with the application of 10- 8 M of each peptide (Fig 
6B). An 111crease of thymidine incorporation into HSC-l cells over 
control level was clearly noted at the concentration of approxi-
~ately 10- 8 M CGRP, PHM, and VIP (data not shown). The pep-
tide NPY, which inhibited forskolin-stimulated cyclic AMP accu-
mulation, did not show any stimulatory or inhibitory effect on cell 
proliferation of HSC-l cells. 
DISCUSSION 
The effects of various neuropeptides found in the sensory and auto-
nomic penpheral neurons of the skin on the inflammatory and 
vascular cells have been investigated and well documented [1,2,26]. 
Ho:wever, the direct effects of neuropeptides on the epidermis re-
mam unclear. In particular, the presence of specific receptors for 
cutaneous neuropeptides on epidermal cells, including keratil1o-
cytes, melanocytes, and dermal fibrobl as ts, have still not been deter-
mined. 
I~ this study, we determined which pep tides directly affect the 
cyclic AMP cascade in keratinocytes through the alteration of 
membrane adenylyl cyclase activity, and then analyzed the effects of 
neuropeptides on the cell growth of keratinocytes. We examined 
more than 20 neuropeptides present in human skin, and we found 
that five common peptides, CGRP, VIP, PHM, GRF, and secretin, 
induced a rapid and substantial illcrease of cyclic AMP formation in 
both NHEK and HSC-l cells (Fig 1A). However, the maximal 
magnitude of cyclic. AMP increase was quite different among the 
peptldes and also differed between NHEK and HSC-l cells. As 
sho~n in Figs 1 and 3, the maximal levels of cyclic AMP after tbe 
application ofPHM and VIP are approximately 30-40 times higher 
than basal levels in HSC-l cells, and these magnitudes are three to 
four times higher than those observed in NHEK cells when the 
same peptide was applied. On the other hand, the levels induced by 
CGRP in HSC-l cells were lower than those observed in NHEK 
cells, which gave an approximately eightfold increase. The varia-
tions in these magnitudes are considered to be caused by differing 
amounts of receptors expressed on the cell membrane, as has been 
indicated in transfected cells with the tachykinin receptor genes 
[23]. 
A 
days 
Figure 6. Mitogenic effects of various neuropeptidcs on culrured keratino-
cytes. A) HSC-l cells were cultured in OMEM with 0.5% FBS in the 
pres~nce of 3 X 10- 8 M o.f various neuropeptides a.nd labeled with [3H)-thy· 
lludllle. The amounts of lIlcorporatcd thymidine were determined by TeA 
precIpItations. The va lues are given as the percentage of the amount of 
incorporated thymidine in the control cells (1273 ± 128 cpm/ well) cul-
tured without pep tides. B) HSC-l cells were cultured in OMEM with 1 % 
FBS in the presence of 10- 8 M of CG RP (opell circles), PHM (closed circles), 
VIP (ofietl sq llares) , or without peptide (closed squares) . The cell numbers were 
counted by Coulter counter daily after peptide application. The values are 
means ± so of three to four experiments in quadruplicate. 
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The peptides CGRP, PHM, VIP, NPY, and SP are known to be 
the major neuronal peptides found in human skin [1,2] . CGRP and 
SP are co-localized in small-diameter sensory nerves and widely 
distributed throughout human skin. The coordinate release of 
CGRP and SP causes a range of biologic responses, referred to as 
neurogenic inflammation [26]. The peptides VIP and PHM are 
encoded by the same gene and co-exist with acetylcholine in post-
ganglionic sympathetic neurons that are closely in contact with the 
eccrine and apocrine glands and hair follicular cells in human skin 
[1,2] . The functiona l properties of VIP and PHM in the mammalian 
skin are thought to be the regulation of secretion by sweat glands in 
combination with acetylcholine. We have determined that CGRP, 
PHM, and VIP stimulate intracellular cyclic AMP formation in 
keratinocytes in a dose-dependent manner (Figs 2, 3), and our data 
also indicate that these rapid and substantial increases of cyclic AMP 
formation are the results of direct stimulation of membrane adeny-
lyl cyclase activity (Fig 5). Recently, the gene for the human VIP 
receptor was cloned, and the VIP receptor has been determined to 
react with PHM, GRF, and secretin [6,27,28] . The potency order 
for the cloned VIP receptor was determined to be VIP> PHM > 
GRF> secretin, which is consistent with the results of our investi-
gation (Fig 3) . From these results we think it is likely that the 
stimulation of the cyclic AMP formation by VIP, PHM, GRF, and 
secretin occurs through the VIP receptor present on keratinocytes. 
Thus, our observations unequivocally demonstrate the presence of 
CGRP and VIP receptors on keratinocytes coupling to stimulator G 
protein (Gs), which directly activates the membrane-bound adeny-
lyl cyclase. Cyclic AMP accumulation induced by CGRP was also 
observed in cultured dermal fibroblasts (manuscript in preparation), 
indicating that CGRP released from the cutaneous sensory nerves 
affects not only the vascular and immune cells but also the keratino-
cytes and fibroblasts of the skin. 
Neuropeptide Y is the major peptide co-messenger in noradre-
nergic sympathetic neurons of most peripheral tissues, and acts as a 
very potent vasoconstrictor individually and in combination with 
co-existing noradrenalin [1]. The present findings show that NPY 
inhibits forskolin-induced cyclic AMP formation in HSC-1 cells, in 
a dose-dependent manner (Fig 4) . The cyclic AMP levels were 
reduced to approximately 80% of the forskolin-stimulated level by 
the addition of10-7 M NPY. Thus, the presence of the NPY recep-
tor that couples to the inhibitory G (Gi) protein is shown in kerati-
nocytes. Furthermore, the activity of the NPY receptor is demon-
strated to be downregulated or even completely eliminated by 
glucocorticoid treatment in keratinocytes. Co-existing adrenaline is 
known to increase intracellular cyclic AMP formation in keratino-
cytes, so the effects of excitation of cutaneous sympathetic neurons 
on keratinocytes are expected to be more complex irl vivo. 
Among the many early events associated with mitogenic stimula-
tion in various cell systems are the increases in cyclic AMP synthesis, 
PI hydrolysis, calcium influx, and the subsequent activation of pro-
tein kinases A and C [29]. In the search for intracellular mechanisms 
important in transducing the mitogenic message of neuropeptides, a 
great deal of interest has been focused on the role of cyclic AMP. 
Peptides that strongly activated adenylyl cyclase in keratinocytes 
also significantly enhanced the DNA synthesis and proliferation of 
HSC-1 cells at the physiologic dose of 10- 8 M (Figs 6A,B), and 
increases in incorporated thymidine showed dose dependency with 
the addition of CGRP, VIP, and PHM (data not shown) . Thus, our 
results indicate the direct stimulatory effects of the cyclic AMP 
cascade on itillitro DNA synthesis and growth in a keratinocyte cell 
line, HSC-1. 
There have been many conflicting reports concerning the effects 
of the increase in the intracellular cyclic AMP on in lIivo and ill lIitro 
proliferation of keratinocytes. Some papers reported that the agents 
increasing the intracellular cyclic AMP levels stimulated keratino-
cyte proliferation [14,15], whereas others suggested inhibitory ef-
fects of cyclic AMP analogs on the growth of keratinocytes [16-
20] . It is very important to recognize, however, that none of the 
cyclic AMP analogs or compounds used to increase the intracellular 
cyclic AMP level work specifically to increase the intracellular cy-
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clic AMP levels [29]; thus these results shou ld be viewed with cau-
tion. Neuropeptides have proven very useful in this regard as en-
dogenous authentic ligands to specifically activate adenylyl cyclase 
and to determine the long-term effects of cyclic AMP accumulation 
in the mammalian skin. Although the regulation of ill villo cell 
proliferation is more complex than that observed in in lIitro cultured 
keratinocytes, one of the most important roles proposed from our 
experiments of the cyclic AMP cascade in keratinocytes is to stimu-
late cellular proliferation. Recently, it has been reported that VIP 
stimulates the proliferation of keratinocytes in a dose-dependent 
manner [30,31]' in agreement with our results. Judging from the 
distribution of peptide-containing nerves, the mitogenic role of 
CGRP may be on epidermal keratinocytes, and VIP jPHM may 
contribute to the replication of epithelial cells of the sweat gland 
and hair follicles. 
There are .many skin diseases: particularly various inflammatory 
dermatoses, 111 wluch neuropeptldes are suspected to work as impor_ 
tant pathogenic factors [2-5,32-34]' VIP-, CGRP-, and SP-con-
taining neurons have been reported to be increased in psoriatic 
plaques, and these pep tides are considered to play modulatory roles 
in psoriatic inflammation [5,32 - 36]. The application of capsaicin 
which specifically depletes neuropeptides, including CGRP and SP: 
f:o~ per!pheral sensory nerves, is known to clinically improve pso-
naUc leSIOns [35,36]. The effecuveness has been explained by the 
action of caps~icin in preven.ting the activ~tion of the infiltrating 
lymphocytes III psonatlc leSIOns by depletlllg the neuropeptides. 
However, a more important effector pathway of capsaicin may be to 
prevent the keratinocyte proliferation induced by neuropeptides 
stimulating cyclic AMP formation, such as CGRP, because hyper-
keratosis and the extravasation of leukocytes are the most character- ! 
istic pathologic features of psoriatic lesions. 
In keratinocytes, it is likely that there are other neuropeptide 
receptors that couple to transducers other than the Gs and Gi pro-
teins described in this investigation. For example, we have found 
that bradykinin stimulates PI hydrolysis in keratinocytes, and the 
subsequent activation of protein kinase C is suggested to be involved 
in the differentiation of keratinocytes (manuscript in preparation) . 
Thus, further investigation including examining other second mes-
sage systems in keratinocytes is necessary to determine the correla-
tion of the second message systems with epidermal cell functions 
and to elucidate the pathologic features of neuropeptides involved 
in various dermatoses. 
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